Shandong Weigao Group Medical Polymer Co. Ltd. ADS
Post# of 250675
Posted On: 11/17/2014 3:12:02 AM
Shandong Weigao Group Medical Polymer Co. Ltd. ADS (SHWGY) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Shandong Weigao Group Medical Polymer Co. Ltd. ADS
Fiscal year is January-December. All values HKD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.13B 2.83B 3.83B 4.54B 5.82B
Cost of Goods Sold (COGS) incl. D&A 998.98M 1.27B 1.71B 1.94B 2.38B
COGS excluding D&A 909.98M 1.16B 1.59B 1.77B 2.13B
Depreciation & Amortization Expense 89M 114M 124.97M 170.06M 251.09M
Depreciation 81.3M 104.41M 113.92M 153.95M 233.22M
Amortization of Intangibles 7.7M 3.57M 3.75M 3.83M 3.93M
Gross Income 1.13B 1.56B 2.12B 2.59B 3.44B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 566.23M 872.87M 1.1B 1.54B 2.12B
Research & Development 88.14M 114.84M 171.04M 209.71M 263.6M
Other SG&A 478.09M 758.03M 932.19M 1.33B 1.86B
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 2.66M 8.23M - -
EBIT after Unusual Expense 0 (2.66M) (8.23M) - -
Non Operating Income/Expense 71.31M 140.16M 3.15B 122.1M (698.45M)
Non-Operating Interest Income 6.8M 6.4M 7.76M 25.19M 8.23M
Equity in Affiliates (Pretax) - - - - -
Interest Expense 4.54M 11.09M 1.38M 5.75M 11.3M
Gross Interest Expense 8.09M 12.31M 5.34M 6.18M 20.53M
Interest Capitalized 3.55M 1.22M 3.97M 433,968 9.23M
Pretax Income 639.99M 792.84M 4.14B 1.18B 604.37M
Income Tax 81.45M 98.18M 149.9M 159.58M 197.43M
Income Tax - Current Domestic 83.75M 101.19M 153.81M 170.21M 195.45M
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (2.29M) (3.01M) (3.92M) (10.63M) 1.98M
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 159.97M 226.36M 182.16M 207.13M 82.19M
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 718.5M 921.02M 4.18B 1.22B 489.14M
Minority Interest Expense (778,439) 3.77M 7.06M (142,607) (384,824)
Net Income 719.28M 917.26M 4.17B 1.23B 489.53M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 719.28M 917.26M 4.17B 1.23B 489.53M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 719.28M 917.26M 4.17B 1.23B 489.53M
EPS (Basic) 0.17 0.21 0.94 0.27 0.11
Basic Shares Outstanding 4.31B 4.31B 4.42B 4.48B 4.48B
EPS (Diluted) 0.17 0.21 0.94 0.27 0.11
Diluted Shares Outstanding 4.31B 4.31B 4.42B 4.48B 4.48B
EBITDA 655.42M 798.37M 1.14B 1.22B 1.57B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Shandong Weigao Group Medical Polymer Co. Ltd. ADS
Fiscal year is January-December. All values HKD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.13B 2.83B 3.83B 4.54B 5.82B
Cost of Goods Sold (COGS) incl. D&A 998.98M 1.27B 1.71B 1.94B 2.38B
COGS excluding D&A 909.98M 1.16B 1.59B 1.77B 2.13B
Depreciation & Amortization Expense 89M 114M 124.97M 170.06M 251.09M
Depreciation 81.3M 104.41M 113.92M 153.95M 233.22M
Amortization of Intangibles 7.7M 3.57M 3.75M 3.83M 3.93M
Gross Income 1.13B 1.56B 2.12B 2.59B 3.44B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 566.23M 872.87M 1.1B 1.54B 2.12B
Research & Development 88.14M 114.84M 171.04M 209.71M 263.6M
Other SG&A 478.09M 758.03M 932.19M 1.33B 1.86B
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 2.66M 8.23M - -
EBIT after Unusual Expense 0 (2.66M) (8.23M) - -
Non Operating Income/Expense 71.31M 140.16M 3.15B 122.1M (698.45M)
Non-Operating Interest Income 6.8M 6.4M 7.76M 25.19M 8.23M
Equity in Affiliates (Pretax) - - - - -
Interest Expense 4.54M 11.09M 1.38M 5.75M 11.3M
Gross Interest Expense 8.09M 12.31M 5.34M 6.18M 20.53M
Interest Capitalized 3.55M 1.22M 3.97M 433,968 9.23M
Pretax Income 639.99M 792.84M 4.14B 1.18B 604.37M
Income Tax 81.45M 98.18M 149.9M 159.58M 197.43M
Income Tax - Current Domestic 83.75M 101.19M 153.81M 170.21M 195.45M
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (2.29M) (3.01M) (3.92M) (10.63M) 1.98M
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 159.97M 226.36M 182.16M 207.13M 82.19M
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 718.5M 921.02M 4.18B 1.22B 489.14M
Minority Interest Expense (778,439) 3.77M 7.06M (142,607) (384,824)
Net Income 719.28M 917.26M 4.17B 1.23B 489.53M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 719.28M 917.26M 4.17B 1.23B 489.53M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 719.28M 917.26M 4.17B 1.23B 489.53M
EPS (Basic) 0.17 0.21 0.94 0.27 0.11
Basic Shares Outstanding 4.31B 4.31B 4.42B 4.48B 4.48B
EPS (Diluted) 0.17 0.21 0.94 0.27 0.11
Diluted Shares Outstanding 4.31B 4.31B 4.42B 4.48B 4.48B
EBITDA 655.42M 798.37M 1.14B 1.22B 1.57B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)